Jennifer L. Caswell-Jin

Oncology

875 Blake Wilbur Dr
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 26, 2026

Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants.

Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants.

Journal: JCO precision oncology

Published: June 03, 2026

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models.

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

Mapping the contributions of adjuvant tamoxifen, 20 years later.

Mapping the contributions of adjuvant tamoxifen, 20 years later.

Journal: Journal of the National Cancer Institute

Published: April 02, 2026

Guideline concordance in triple-negative breast cancer: What does it measure?

Guideline concordance in triple-negative breast cancer: What does it measure?

Journal: Cancer

Published: March 29, 2026

Reply to: Comment on Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer Treatment Costs and Cost-Effectiveness.

Reply to: Comment on Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer Treatment Costs and Cost-Effectiveness.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 24, 2025

Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy.

Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy.

Journal: Breast cancer research and treatment

Published: August 29, 2025

RIG-I-dependent tumor-intrinsic type I interferon signaling restricts growth in breast cancer 3D culture.

RIG-I-dependent tumor-intrinsic type I interferon signaling restricts growth in breast cancer 3D culture.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

Physician Specialization and Receipt of Updated Breast Cancer Care in the United States: A SEER-Medicare Analysis.

Physician Specialization and Receipt of Updated Breast Cancer Care in the United States: A SEER-Medicare Analysis.

Journal: JCO oncology practice

Published: July 02, 2025

Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer.

Cost and Cost-Effectiveness of Treating Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 21, 2025

Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care.

Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care.

Journal: JAMA oncology

Published: April 24, 2025

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020.

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020.

Journal: JAMA oncology

Published: December 05, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026